1. Home
  2. RDHL vs EDBL Comparison

RDHL vs EDBL Comparison

Compare RDHL & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • EDBL
  • Stock Information
  • Founded
  • RDHL 2009
  • EDBL 2020
  • Country
  • RDHL Israel
  • EDBL United States
  • Employees
  • RDHL N/A
  • EDBL N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • RDHL Health Care
  • EDBL Consumer Staples
  • Exchange
  • RDHL Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • RDHL 3.9M
  • EDBL 4.0M
  • IPO Year
  • RDHL N/A
  • EDBL 2022
  • Fundamental
  • Price
  • RDHL $1.02
  • EDBL $1.18
  • Analyst Decision
  • RDHL
  • EDBL
  • Analyst Count
  • RDHL 0
  • EDBL 0
  • Target Price
  • RDHL N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • RDHL 1.6M
  • EDBL 87.6K
  • Earning Date
  • RDHL 09-05-2025
  • EDBL 11-14-2025
  • Dividend Yield
  • RDHL N/A
  • EDBL N/A
  • EPS Growth
  • RDHL N/A
  • EDBL N/A
  • EPS
  • RDHL N/A
  • EDBL N/A
  • Revenue
  • RDHL $9,550,000.00
  • EDBL $12,553,000.00
  • Revenue This Year
  • RDHL $381.91
  • EDBL $29.56
  • Revenue Next Year
  • RDHL N/A
  • EDBL $20.00
  • P/E Ratio
  • RDHL N/A
  • EDBL N/A
  • Revenue Growth
  • RDHL 157.62
  • EDBL N/A
  • 52 Week Low
  • RDHL $1.02
  • EDBL $1.21
  • 52 Week High
  • RDHL $8.75
  • EDBL $13.50
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 31.69
  • EDBL 28.46
  • Support Level
  • RDHL $1.02
  • EDBL $1.57
  • Resistance Level
  • RDHL $1.11
  • EDBL $1.43
  • Average True Range (ATR)
  • RDHL 0.14
  • EDBL 0.10
  • MACD
  • RDHL -0.01
  • EDBL -0.03
  • Stochastic Oscillator
  • RDHL 3.45
  • EDBL 11.32

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: